Lilly Wins First Zyprexa Liability Trial

Law360, Los Angeles (November 4, 2011, 9:55 PM EDT) -- In the first such case to make it to a verdict after more than $1 billion in settlements, a California jury on Friday ruled in favor of Eli Lilly & Co. in a product liability lawsuit over the company’s $5 billion-a-year blockbuster antipsychotic drug Zyprexa.

The Los Angeles jury rejected claims that Lilly had caused the 2007 death of 20-year-old Cody Tadai by failing to adequately warn doctors about the drug’s possible side effects, causing Cody’s psychiatrist to misjudge the risk of prescribing him the drug....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.